Authors: Prakash, TP Kawasaki, AM Johnston, JF Graham, MJ Condon, TP Manoharan, M

Citation: Tp. Prakash et al., Antisense properties of 2 '-O-dimethylaminooxyethyl (2 '-O-DMAOE) oligonucleotides, NUCLEOS NUC, 20(4-7), 2001, pp. 829-832

Authors: Rudin, CM Holmlund, J Fleming, GF Mani, S Stadler, WM Schumm, P Monia, BP Johnston, JF Geary, R Yu, RZ Kwoh, TJ Dorr, FA Ratain, MJ

Citation: Cm. Rudin et al., Phase I trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer, CLIN CANC R, 7(5), 2001, pp. 1214-1220

Authors: Mote, PA Johnston, JF Manninen, T Tuohimaa, P Clarke, CL

Citation: Pa. Mote et al., Detection of progesterone receptor forms A and B by immunohistochemical analysis, J CLIN PATH, 54(8), 2001, pp. 624-630

Authors: Cunningham, CC Holmlund, JT Geary, RS Kwoh, TJ Dorr, A Johnston, JF Monia, B Nemunaitis, J

Citation: Cc. Cunningham et al., A phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma, CANCER, 92(5), 2001, pp. 1265-1271

Authors: Stepkowski, SM Qu, XM Wang, ME Tian, L Chen, WH Wancewicz, EV Johnston, JF Bennett, CF Monia, BP

Citation: Sm. Stepkowski et al., Inhibition of C-raf expression by antisense oligonucleotides extends heartallograft survival in rats, TRANSPLANT, 70(4), 2000, pp. 656-661